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Abstract
Objective
Among ischemic stroke patients with negative CT angiography (CTA), we aimed to determine
the predictive value of enhanced distal vessel occlusion detection using CT perfusion
postprocessing (waveletCTA) for the treatment eﬀect of IV thrombolysis (IVT).
Methods
Patients were selected from 1,851 consecutive patients who had undergone CT perfusion.
Inclusion criteria were (1) signiﬁcant cerebral blood ﬂow (CBF) deﬁcit, (2) no occlusion on
CTA, and (3) infarction conﬁrmed on follow-up. Favorable morphologic response was deﬁned
as smaller values of ﬁnal infarction volume divided by initial CBF deﬁcit volume (FIV/CBF).
Favorable functional outcome was deﬁned as modiﬁed Rankin Scale score of ≤2 after 90 days
and decrease in NIH Stroke Scale score of ≥3 from admission to 24 hours (ΔNIHSS).
Results
Among patients with negative CTA (n = 107), 58 (54%) showed a distal occlusion on wave-
letCTA. There was no diﬀerence between patients receiving IVT (n = 57) vs supportive care
(n = 50) regarding symptom onset, early ischemic changes, perfusion mismatch, or admission
NIHSS score (all p > 0.05). In IVT-treated patients, the presence of an occlusion was an
independent predictor of a favorable morphologic response (FIV/CBF: β −1.43; 95% conﬁ-
dence interval [CI] −1.96, −0.83; p = 0.001) and functional outcome (90-day modiﬁed Rankin
Scale: odds ratio 7.68; 95% CI 4.33–11.51; p = 0.039; ΔNIHSS: odds ratio 5.76; 95% CI
3.98–8.27; p = 0.013), while it did not predict outcome in patients receiving supportive care
(all p > 0.05).
Conclusion
In stroke patients with negative CTA, distal vessel occlusions as detected by waveletCTA are an
independent predictor of a favorable response to IVT.
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IV thrombolysis (IVT) has been the mainstay of ischemic
stroke therapy since 1995.1 Its goal is reperfusion of ischemic
tissue by targeting occluded arteries, usually detected by CT
angiography (CTA). While some studies showed beneﬁts of
IVT in patients without occlusions on CTA,2,3 other studies
did not.4,5 Several recent studies demonstrated larger treat-
ment eﬀects of IVT in patients with vessel occlusions.4–6
The function of IVT relates to recanalization. However, re-
canalization does not always lead to reperfusion as suggested
by preclinical7 and clinical observations.8–10 The no-reﬂow
phenomenon refers to persisting perfusion lesions despite
macrovascular recanalization and may be caused by micro-
vascular obstruction.7,11–13 As spontaneous recanalization
occurs,14,15 improved detection of blood clots as IVT targets
may be important. Despite growing evidence, occlusions are
not considered decision-relevant for IVT by current
recommendations.16,17
Angiography examinations are routinely performed as single-
phase CTA to detect proximal occlusions, which are required
for thrombectomy.18 However, drawbacks in CTA include
low contrast-to-noise ratio,19 venous superimposition,20 and
scan timing imprecisions,21 increasing the risk of missing
vessel occlusions. Approximately one-third of centers rou-
tinely use CT perfusion (CTP),22 a dynamic acquisition of the
brain. To overcome some CTA limitations, eﬀorts were made
to reconstruct angiographic data from CTP.19,23 Among
these, CTP-based wavelet-transformed angiography (wave-
letCTA) enables distal occlusion detection in about 50% of
patients without CTA evidence of occlusion but infarction
conﬁrmed on follow-up.24
Therefore, our aim was to determine the predictive value of
distal vessel occlusions detected by waveletCTA in patients
with ischemic stroke but negative CTA.
Methods
Standard protocol approvals, registrations,
and patient consents
The institutional review board of the LMU Munich (Ethik-
kommission der Medizinischen Fakulta¨t der Ludwig-Max-
imilians-Universita¨t Mu¨nchen) approved this retrospective
study, which was conducted according to the Helsinki
Declaration of 2013, and waived requirement for informed
consent. Based on a prospectively collected stroke registry,
our initial cohort consisted of 1,851 consecutive patients who
had undergone multiparametric CT including CTP for
suspected ischemic stroke between December 2012 and
December 2016.
From this cohort, we included all patients with (1) signiﬁcant
cerebral blood ﬂow (CBF) deﬁcits on CTP, (2) missing evi-
dence of vessel occlusion on CTA, and (3) acute ischemic
infarction as conﬁrmed by follow-up MRI or CT within 72
hours. We excluded patients with (1) nondiagnostic quality or
incomplete raw datasets of CTP or CTA, (2) lacunar etiology
of stroke, and (3) hemodynamic infarction pattern.
A signiﬁcant CBF deﬁcit was deﬁned as the presence of a focal
decrease in the color-coded CBF maps compared to the
contralateral side on a minimum of 2 adjacent slices. Nineteen
CTP examinations had to be excluded based on non-
diagnostic CTP quality or incomplete raw CTP datasets.
Among 1,832 diagnostic CTP examinations, we excluded 955
patients without CBF deﬁcits, 655 patients with CTA-
detected occlusions, 45 patients because of missing follow-up
imaging, 29 patients because of missing infarction on follow-
up imaging, 35 patients with conﬁrmed lacunar stroke, and 6
patients with conﬁrmed hemodynamic stroke. The ﬂowchart
of patient selection is shown in ﬁgure 1. For the functional
outcome analysis, patients with prestroke disability as
assessed by the premorbid modiﬁed Rankin Scale (mRS) with
scores >1 and patients with missing clinical follow-up were
excluded.
CT examination protocol, image
postprocessing, and wavelet transform
All patients underwent standardized CT protocols consisting
of noncontrast CT (NCCT), CTA, and CTP (the detailed
acquisition protocol has been previously described24). We
used the angiographic reconstruction of waveletCTA from
CTP as described in detail and used in previous studies.24–26
Brieﬂy, the principle of the algorithm is an analysis of each
voxel’s time attenuation curve with respect to its resemblance
to the shape of a generic contrast bolus time attenuation
curve. The wavelet transform then translates this resemblance
into a power spectrum, of which the maximal values are
interpreted as the angiographic signal intensity. An illustration
of the angiographic reconstruction is provided in ﬁgure e-1
(links.lww.com/WNL/A439).
Image analysis
Early ischemic changes on NCCT were assessed using the
Alberta Stroke Program Early CT Score27 in the case of
middle cerebral artery infarction. As there are no established
Glossary
CBF = cerebral blood ﬂow; CBV = cerebral blood volume; CI = conﬁdence interval; CTA = CT angiography; CTP = CT
perfusion; FIV = ﬁnal infarction volume; IVT = IV thrombolysis; mRS = modiﬁed Rankin Scale; NCCT = noncontrast CT;
NIHSS = NIH Stroke Scale; OR = odds ratio; SC = supportive care; waveletCTA = CT perfusion-based wavelet-transformed
angiography.
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scores for other vascular areas outside the middle cerebral
artery territory, we assessed such cases in a binary fashion
determining either presence or absence of early ischemic
changes.28 All CTA examinations of the initial study cohort
were reviewed in detail for vessel occlusions using multi-
planar reconstructions with the option of maximum
intensity projections by 2 experienced radiologists, a board-
certiﬁed attending (W.H.S.) with more than 10 years of
experience and a board-certiﬁed fellow (K.M.T.) with more
than 6 years of experience in stroke imaging. CBF deﬁcit,
cerebral blood volume (CBV) deﬁcit, and ﬁnal infarction
were volumetrically measured based on expert delineation
using OsiriX v.8.0.2 imaging software (Pixmeo, Bernex,
Switzerland) as previously described,29 an approach that has
been shown to be reliable and valid.29–31 CBF-CBV mis-
match was calculated as absolute volume (CBF deﬁcit vol-
ume − CBV deﬁcit volume) and as relative mismatch ([CBF
deﬁcit volume − CBV deﬁcit volume]/CBF deﬁcit volume).
Final infarction volume (FIV) was assessed using diﬀusion-
weighted MRI (b = 1,000 s/mm2) or NCCT. Two readers
independently evaluated the waveletCTA images for vessel
occlusions and their location. Readers were blinded to all
clinical data and any other imaging studies or
reconstructions.
Morphologic and functional outcome analysis
The primary morphologic outcome parameter was FIV. As
secondary morphologic outcome, we determined parameters
that represent the morphologic course from ischemia to in-
farction as applied in previous studies,32–35 indicating the
morphologic response to treatment. To quantify the change
from initial hemodynamic impairment to ﬁnal infarcted tissue,
we used 3 calculated parameters as surrogates: FIV divided by
the CBF deﬁcit volume (FIV/CBF) is a ratio of infarction to
the initial ischemia. FIV divided by CBV deﬁcit volume (FIV/
CBV) represents a ratio of infarction to initial ischemic core.
FIV minus the ischemic core volume divided by the ischemic
penumbra volume ([FIV − CBV]/[CBF − CBV]) indicates
the progression of the ischemic area to the infarcted pen-
umbra. For all 3 parameters alike, smaller values imply more
favorable morphologic outcomes.
The functional outcome was assessed using the mRS score
upon discharge and after 90 days. In addition, the NIH Stroke
Scale (NIHSS) score was assessed on admission and after 24
hours. Ninety-day mRS score was deﬁned as the primary
functional outcome parameter. Discharge mRS score and
change of the NIHSS score from admission to 24 hours
(DNIHSS ≥3) as a marker of early neurologic improvement
Figure 1 Flowchart of patient selection
CBF = cerebral blood flow; CTA = CT angiography; CTP = CT
perfusion; mRS = modified Rankin Scale.
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were used as secondary functional outcome parameters.
Prestroke disability was also evaluated using the mRS. Clinical
reasons for withholding IVT treatment are supplied in table
e-1 (links.lww.com/WNL/A440).
Statistical analysis
We performed all statistical analyses using SPSS Statistics 23
(IBM, Armonk, NY). Interreader agreement was assessed us-
ing Cohen κ. The study population was ﬁrst stratiﬁed in 4
subgroups according to treatment status and detection of
vessel occlusions. A χ2 test was performed for the group
comparison of categorical variables. In case of continuous
variables, group comparisons were analyzed by analysis of
variance; in case of ordinal variables, a Kruskal-Wallis test was
used. Multivariate linear and binary logistic regression analyses
were performed to test the association between predictors and
the dependent morphologic and functional outcome variables.
These analyses were adjusted for age, sex, NIHSS score on
admission, early ischemic changes on NCCT, CBF deﬁcit
volume, CBV deﬁcit volume, as well as the relative CBF-CBV
mismatch. All metric and ordinal variables are presented as
median (interquartile range). Normal distributionwas assessed
using the Kolmogorov-Smirnov test. Categorical variables are
presented as frequency and percentage. Two-sided p values
<0.05 were considered to indicate statistical signiﬁcance.
Data availability
Anonymized data will be shared by request from any qualiﬁed
investigator.
Results
Patient characteristics
The study population of 107 patients was analyzed in sub-
groups according to the treatment status (IVT vs supportive
care [SC]) and presence of a vessel occlusion as detected by
waveletCTA (occlusion vs no occlusion). The detailed patient
characteristics are shown in table 1. Overall, in 58 (54%) of all
patients with negative CTA, an occlusion was detected using
waveletCTA. The interreader agreement of vessel occlusion
detection was very good (Cohen κ = 0.864).
IVT was administered in 57 patients (53%); the remaining
50 patients received SC. The detected vessel occlusions
showed similar distribution across vascular segments in
IVT- and SC-treated patients (all with p > 0.05). Group
comparisons showed no diﬀerences in age, sex, time from
symptom onset, presence of early ischemic changes, Alberta
Stroke Program Early CT Score, relative CBF-CBV mis-
match, or admission NIHSS score (all with p > 0.05).
Occlusions detected by waveletCTA were not associated
with the premorbid or admission functional status (all with
p > 0.05). Diﬀerences among the groups were observed for
CBF deﬁcit volume, primary morphologic outcome
parameters (FIV), as well as primary (90-day mRS score)
and secondary functional outcome parameters (discharge
mRS score, DNIHSS) (all with p < 0.05). Regression
analyses were performed for further statistical analyses re-
garding independent associations with morphologic and
functional outcome parameters.
Predictors of morphologic outcome
In both treatment groups, no association of waveletCTA-
detected occlusions with the primary outcome parameter
FIV was present (all with p > 0.05); a moderate association
for a favorable outcome was observed within the IVT-
treated group (β −7.43; 95% conﬁdence interval [CI]
−14.86, 1.82; p = 0.107). In patients receiving IVT, the
presence of waveletCTA-detected occlusions demonstrated
an association with smaller values of the morphologic re-
sponse parameters FIV/CBF (β −1.43; 95% CI −1.96,
−0.83; p = 0.001) and (FIV − CBV)/(CBF − CBV) (β
−4.54; 95% CI −7.02, −2.07; p = 0.001), indicating a fa-
vorable response, whereas no associations were found for
patients who received SC (all with p > 0.05). The results of
the regression analysis are presented in table 2. Represen-
tative patient examples for the IVT treatment response are
shown in ﬁgure 2. Graphic representations of the mor-
phologic outcome parameters are provided in ﬁgures e-2 to
e-4 (links.lww.com/WNL/A439).
Predictors of functional outcome
In patients receiving IVT, associations for the presence of
a waveletCTA-detected occlusion with favorable primary
(90-day mRS score ≤2: odds ratio [OR] 7.68; 95% CI
4.33–11.51; p = 0.039) and secondary functional outcome
parameters (discharge mRS score ≤2: OR 8.33; 95% CI
3.74–12.45; p = 0.042; DNIHSS ≥3: OR 5.76; 95% CI
3.98–8.27; p = 0.013) were observed, whereas no associations
were found for SC-treated patients (all with p > 0.05). The
results of the logistic regression analysis are presented in
table 3. Furthermore, an mRS reduction shift analysis yielded
comparable results (table e-2, links.lww.com/WNL/A440). A
visual representation of the clinical course of the NIHSS score
between admission and 24 hours thereafter is provided in
ﬁgure e-5 (links.lww.com/WNL/A439).
Discussion
This study investigated the predictive value of waveletCTA-
based detection of distal vessel occlusions that are not evi-
dent on CTA in patients with acute ischemic stroke. Patients
with such occlusions who received IVT, in contrast to
patients who received only SC, had more favorable mor-
phologic outcomes independent of established predictors
such as admission NIHSS score, early ischemic changes, or
CBF-CBV mismatch. Regarding functional outcome, IVT-
treated patients with waveletCTA-detected occlusions, as
opposed to patients treated with SC, had more favorable
primary and secondary functional outcomes, particularly
a better neurologic improvement measured by the diﬀer-
ence in the NIHSS scores between admission and 24 hours
thereafter.
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Table 1 Patient characteristics stratified by IV thrombolysis treatment and occlusion detection
IV thrombolysis (n = 57) Supportive care (n = 50)
p ValueOcclusion (n = 35) No occlusion (n = 22) Occlusion (n = 23) No occlusion (n = 27)
Patient data
Age, y 75 (67–83) 71 (67–79) 73 (64–79) 76 (70–80) 0.820
Sex, male, n (%) 24 (68.6) 11 (50.0) 16 (69.6) 15 (55.5) 0.391
Time from symptom onseta 105 (90–150) 153 (105–210) 105 (60–210) 135 (113–233) 0.156
MCA stroke, n (%) 29 (82.9) 17 (77.3) 18 (78.3) 20 (74.1) 0.457
Imaging data
Early ischemic changes, n (%) 10 (28.6) 6 (27.3) 8 (34.8) 9 (33.3) 0.393
ASPECTS 10 (9–10) 10 (9–10) 9 (9–10) 10 (9–10) 0.431
Extracranial ≥70% stenosis, n (%) 2 (5.7) 1 (4.5) 1 (4.3) 1 (3.7) 0.884
CBF deficit volume 24 (13–39) 8 (2–18) 18 (13–30) 6 (3–13) <0.001b
CBV deficit volume 5 (2–11) 3 (2–6) 6 (2–16) 2 (2–5) 0.122
CBF-CBV mismatch, % 77 (66–87) 68 (48–81) 66 (50–78) 63 (31–80) 0.124
Final infarction volume 3 (2–15) 7 (2–22) 14 (6–38) 3 (2–8) 0.011b
Functional data
Admission NIHSS 6 (5–9) 9 (4–14) 6 (3–9) 4 (2–7) 0.436
24-h NIHSSa 2 (1–3) 7 (3–13) 7 (5–9) 3 (1–5) 0.001b
DNIHSS (admission to 24 h) 4 (3–6) 0 (0–2) −1 (−2–0) 0 (0–1) <0.001b
Premorbid mRS 0 (0–1) 0 (0–1) 1 (0–3) 0 (0–0) 0.079
Discharge mRSa 1 (1–2) 3 (2–4) 3 (2–4) 2 (1–4) 0.015b
90-d mRSa 1 (0–1) 1 (1–3) 3 (2–6) 1 (0–2) 0.031b
Cardiovascular risk factors, n (%)
Arterial hypertension 25 (71.4) 11 (50.0) 14 (63.6) 19 (76.0) 0.245
Atrial fibrillation 10 (28.6) 6 (27.3) 10 (45.5) 6 (24.0) 0.396
Smoking 13 (37.1) 3 (13.6) 8 (36.4) 9 (36.0) 0.238
Hypercholesterolemia 9 (25.7) 7 (31.8) 5 (22.7) 6 (24.0) 0.905
Diabetes mellitus 7 (20.0) 4 (18.2) 6 (27.3) 7 (28.0) 0.791
Etiology of stroke, n (%)
Cardioembolic 11 (31.4) 10 (45.5) 10 (43.5) 9 (33.3) 0.638
Arterioarterial 13 (37.1) 9 (40.9) 6 (26.1) 9 (33.3) 0.743
Other determined 1 (2.9) 0 (0.0) 3 (13.0) 2 (7.4) NA
Undetermined 10 (28.6) 3 (13.6) 4 (17.4) 7 (25.9) 0.520
Complications, n (%)
Hemorrhagic infarction NA
Type 1 2 (5.7) 1 (4.5) 0 (0.0) 3 (11.1)
Type 2 2 (5.7) 0 (0.0) 3 (13.0) 1 (3.7)
Parenchymal hematoma NA
Type 1 0 (0.0) 1 (4.5) 1 (4.3) 1 (3.7)
Continued
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Regardless of the recent success of endovascular thrombec-
tomy in patients with large-vessel occlusions, IVT is still the
mainstay of ischemic stroke therapy in the majority of
patients.1,17 Stroke patients without evidence of a vessel oc-
clusion are known to have better functional outcomes.36,37
However, there is no consensus on the diﬀerential treatment
eﬀect of IVT in patients with compared to patients without
vessel occlusions. While earlier studies suggest that patients
without evidence of vessel occlusions beneﬁt from IVT,2,3 2
recent, large studies were not able to ﬁnd a signiﬁcant beneﬁt
of IVT for this patient subgroup.4,5 Another recent study on
patients with small perfusion deﬁcits of <15mL, of which only
15% showed an occlusion, also showed no beneﬁt of IVT
regarding functional outcome.38
The evaluation of patients with waveletCTA for the presence
or absence of distal vessel occlusions, however, allows fur-
ther classiﬁcation of patients with negative CTA. The dif-
ferential treatment eﬀect of IVT in patients with compared
to patients without waveletCTA-detected occlusions in our
study could represent a possible explanation for the diﬀer-
ences that were observed in the above-mentioned studies.
From a pathophysiologic point of view, the vessel-occluding
clot as the primary target of a thrombolytic therapy
Table 1 Patient characteristics stratified by IV thrombolysis treatment and occlusion detection (continued)
IV thrombolysis (n = 57) Supportive care (n = 50)
p ValueOcclusion (n = 35) No occlusion (n = 22) Occlusion (n = 23) No occlusion (n = 27)
Type 2 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Extraischemic ICH 1 (2.9) 0 (0.0) 1 (4.3) 2 (7.4) NA
Space-occupying edema 0 (0.0) 0 (0.0) 1 (4.3) 1 (3.7) NA
Abbreviations: ASPECTS = Alberta Stroke Program Early CT Score; CBF = cerebral blood flow; CBV = cerebral blood volume; ICH = intracranial hemorrhage;
MCA = middle cerebral artery; mRS = modified Rankin Scale; NA = not applicable; NIHSS = NIH Stroke Scale.
Values presented are n (%) for categorical variables and median (interquartile range) for ordinal and continuous variables. Proportion analysis tests for
categorical variables were performed using the χ2 test. Nonparametric tests for continuous variables were performed using analysis of variance and for
ordinal variables using the Kruskal-Wallis test.
a Missing values: time from symptom onset 31/107, discharge mRS 4/107, 24-hour NIHSS 4/107, 90-day mRS 17/107.
b Statistically significant.
Table 2 Distal vessel occlusions and morphologic outcome in treatment subgroups
Independent variable
Dependent morphologic outcome variables
IV thrombolysis Supportive care
β (95% CI) p Value β (95% CI) p Value
Distal vessel occlusiona FIV
−7.43 (−14.86, 1.82) 0.107 8.76 (−11.51, 29.02) 0.386
Distal vessel occlusiona Ratio of FIV to admission total
ischemic volume (FIV/CBF)b
−1.43 (−1.96, −0.83) 0.001c 0.47 (−0.06, 1.01) 0.081
Distal vessel occlusiona Ratio of FIV to admission core
ischemic volume (FIV/CBV)d
−1.92 (−4.76, 0.92) 0.080 1.01 (0.80, 2.81) 0.264
Distal vessel occlusiona Ratio of final penumbral infarction
volume to admission
penumbral ischemic volume
([FIV − CBV]/[CBF − CBV])e
−4.54 (−7.02, −2.07) 0.001c 1.86 (−1.63, 5.35) 0.285
Abbreviations: CBF = cerebral blood flow; CBV = cerebral blood volume; CI = confidence interval; FIV = final infarction volume.
A multivariate linear regression analysis was performed for the indicated morphologic outcome parameters for the patients receiving IV thrombolysis or
supportive care.
a Adjusted for age, sex, admission NIH Stroke Scale, early ischemic changes, size of the perfusion deficit on CBF and CBV, as well as the percentage of CBF-CBV
mismatch.
b Total ischemic volume is based on the size of the CBF perfusion deficit.
c Statistically significant.
d Core ischemic volume is based on the size of the CBV perfusion deficit.
e Penumbral ischemic volume is calculated as the size of the CBF minus the CBV perfusion deficit.
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represents a possible reason for the larger IVT treatment
eﬀect observed in our study.
Of note, waveletCTA-detected occlusions in IVT-treated
patients were associated with favorable morphologic outcome
parameters FIV/CBF and (FIV − CBV)/(CBF − CBV),
which both consider the ischemic penumbra, but not FIV/
CBV, which only accounts for the progression of the ischemic
core to the ﬁnal infarction. This could be explained by the
pathophysiologic concept that distinguishes irreversibly
Figure 2 Patient examples for the IV thrombolysis treatment response
(A) A 59-year-old man and (B) a 56-year-old man presented with a right-sided hemiparesis and similar NIHSS scores on admission, TfSO, ASPECTS, and CTP
mismatch. Both patients received immediate IV thrombolysis treatment. In patient A, anM3 segment vessel occlusion not evident on CTAwas identified using
waveletCTA (white arrow). In contrast, no occlusions were evident in patient B, neither on CTA nor on waveletCTA. Patient A showed a favorablemorphologic
and clinical outcome (final infarction volume: 1.2mL; CBF deficit volume: 16.5mL; 90-daymRS score: 1). Patient B demonstrated an unfavorablemorphologic
as well as clinical outcome (final infarction volume: 25.4 mL; CBF deficit volume: 28.2 mL; 90-day mRS score: 3). CTA and waveletCTA are presented as
maximum intensity projections. ASPECTS = Alberta Stroke Program Early CT Score; CBF = cerebral blood flow; CBV = cerebral blood volume; CTA = CT
angiography; CTP = CT perfusion; DWI = diffusion-weighted imaging; mRS =modified Rankin Scale; NCCT = noncontrast CT; NIHSS = NIH Stroke Scale; TfSO =
time from symptom onset.
Table 3 Distal vessel occlusions and functional outcome in treatment subgroups
Independent variable
Dependent functional outcome variables
IV thrombolysis Supportive care
Adjusted OR (95% CI) p Value Adjusted OR (95% CI) p Value
Distal vessel occlusiona 90-d mRS ≤2
7.68 (4.33, 11.51) 0.039b 1.71 (0.46, 6.37) 0.362
Distal vessel occlusiona Discharge mRS ≤2
8.33 (3.74, 12.45) 0.042b 0.64 (0.02, 17.62) 0.811
Distal vessel occlusiona NIHSS improvement from
admission to 24 h (DNIHSS ≥3)
5.76 (3.98, 8.27) 0.013b 0.25 (0.01, 18.77) 0.258
Abbreviations: CI = confidence interval; mRS = modified Rankin Scale; NIHSS = NIH Stroke Scale; OR = odds ratio.
A binary logistic regression analysis was performed for the indicated functional outcome parameters for the patients receiving IV thrombolysis or supportive
care.
a Adjusted for age, sex, admissionNIHSS, early ischemic changes, size of the perfusion deficit on cerebral blood flow (CBF) and cerebral blood volume (CBV), as
well as the percentage of CBF-CBV mismatch.
b Statistically significant.
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damaged brain tissue (ischemic core) and potentially sal-
vageable tissue at risk (ischemic penumbra). Integrating our
observations in this concept, IVTmight therefore be unable to
inﬂuence the progression of the ischemic core to the ﬁnal
infarction irrespective of available therapeutic targets in the
form of vessel occlusions.
Despite proven ischemic lesions on CTP imaging, we only
observed underlying vessel occlusions in about half of the
patients. Possible explanations are that (1) spontaneous re-
canalization has already occurred by the time of
admission14,15 or that (2) waveletCTA misses smaller occlu-
sions because of the limited spatial resolution of contempo-
rary CT imaging. The presence of a high-grade extracranial
stenosis was very low in the study population and evenly
distributed across the subgroups. We therefore consider it
unlikely that the ischemic lesions could have resulted from an
extracranial stenosis.
The persistence of perfusion lesions despite macrovascular
recanalization, also termed the no-reﬂow phenomenon, has
been observed by several basic science studies on ischemic
stroke7,11,12 as well as in human clinical ischemic stroke
trials.8–10 It is known that oxidative stress signals resulting
from hypoperfusion lead to microvascular obstruction medi-
ated by capillary pericytes.11,12 Targeting this mechanism
conferred neuroprotection and improved outcomes in animal
models of ischemic stroke,13 but the relevance in humans
remains unclear. In this pathophysiologic context, the added
value of waveletCTA may be to triage patients with acute
ischemic perfusion lesions based on the presence of a mac-
rovascular occlusion, which represents the main target of IVT.
Despite the well-proven beneﬁts of IVT, undertreatment of
patients with stroke remains an issue.39 A recent survey
demonstrated that CTA ﬁndings are important inﬂuencing
factors for 41% of North American neurologists in their
decision of IVT administration.40 Thus, the identiﬁcation
of additional occlusions using angiographic CTP post-
processing techniques may support the decision-making
process to increase diagnostic conﬁdence and the use of
IVT. However, in light of equivocal data on the beneﬁt of
IVT in patients without evidence of occlusions on CTA, this
aspect is not considered in the current guidelines on stroke
management.16,17
There are limitations to this study that need to be considered
when interpreting the results. First, this is a single-center
study with a limited number of patients. However, because
our results were consistent among diﬀerent morphologic and
functional parameters, we assume that larger studies will come
to similar conclusions. Second, the retrospective design of our
study makes it potentially prone to selection bias. Nonethe-
less, all enrolled patients were recruited from a prospectively
collected stroke registry, and standardized stroke protocols
were applied to minimize this potential bias. Third, based
on the study design, no diagnostic standard of reference for
waveletCTA-detected occlusions is available. However, in
a previous diagnostic accuracy study using stroke patients
with CTA-proven occlusions and control patients without
follow-up infarction, waveletCTA demonstrated high speci-
ﬁcity for occlusion detection.24 On the other hand, it should
be acknowledged that the sensitivity of waveletCTA may be
limited and that other reconstruction techniques may yield
similar results. Fourth, expert visual delineation of CTP
lesions was applied for volumetric assessment as the manu-
facturer’s automated analysis was not applicable to all vascular
territories, and misclassiﬁcation of medium-sized lesions was
observed. Because no threshold could be applied in this
approach, a diﬀerentiation from benign oligemic changes is
potentially limited. Yet, all patients were included on the basis
of a follow-up–conﬁrmed infarction. Moreover, reliability and
validity of this approach has been shown by several
studies.29–31 Nevertheless, further studies with larger patient
cohorts will need to be conducted to validate the prognostic
relevance of distal vessel occlusions with respect to eﬃcacy
and safety of IVT.
In our study on patients with acute ischemic stroke, distal
vessel occlusions as detected using wavelet-based CTP
postprocessing predicted a favorable response to IVT
and may have potential implications in clinical decision-
making.
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Study question
Can enhanced distal vessel occlusion detection with CT
perfusion (CTP)-based wavelet-transformed angiography
(waveletCTA) predict responses to intravenous thrombolysis
(IVT) in ischemic stroke patients who test negative for vessel
occlusions in CT angiography (CTA)?
Summary answer
Distal vessel occlusions detected with waveletCTA in-
dependently predict favorable responses to IVT in ischemic
stroke patients with negative CTA results.
What is known and what this paper adds
IVT provides reperfusion of ischemic tissue by targeting oc-
cluded vessels. Prior studies suggested larger treatment ben-
eﬁts for patients with evidence of occlusion. This study shows
that by providing enhanced detection of vessel occlusions,
waveletCTA can predict the response to IVT in ischemic
stroke patients with negative CTA results.
Participants and setting
This study analyzed 107 patients with acute ischemic stroke
who underwent CT imaging at Munich’s Ludwig-Maximilians-
University Hospital between December 2012 and December
2016. This group included 57 patients treated with IVT (61%
male) and 50 patients treated with supportive care (SC; 62%
male). All participants exhibited cerebral blood ﬂow (CBF)
deﬁcits on CTP scans and had negative CTA results.
Design, size, and duration
The waveletCTA images obtained by processing CTP scans
were reviewed by 2 experienced radiologists to identify vessel
occlusions. The radiologists were blinded to clinical
information.
Primary outcomes
The primary morphologic outcome was the ﬁnal infarction
volume divided by the initial CBF deﬁcit volume, with smaller
ratios being considered more favorable. The primary func-
tional outcome was the modiﬁed Rankin Scale (mRS) score
after 90 days, with scores ≤2 being deﬁned as favorable.
Main results and the role of chance
The waveletCTA images revealed distal occlusions in 58
(54%) participants. In the IVT-treated patients, waveletCTA-
detected distal vessel occlusions predicted favorable mor-
phologic outcomes (p = 0.001) and favorable functional
outcomes (p = 0.039). In the SC-treated patients,
waveletCTA-detected distal vessel occlusions did not predict
favorable morphologic outcomes (p = 0.081) or favorable
functional outcomes (p = 0.362).
Bias, confounding, and other reasons
for caution
This study’s retrospective nature made it prone to selection
bias. As invasive angiography is not clinically indicated in this
population, no diagnostic standard of reference for wavelet
CTA-detected occlusions was available.
Generalizability to other populations
This was a single-center study with a small group of patients,
so the generalizability of the results may be limited.
Study funding/potential competing interests
This study received no funding, and the authors report no
competing interests. Go to Neurology.org/N for full
disclosures.
Table Predictive power of waveletCTA-detected distal
vessel occlusions for favorable morphologic and
functional outcomes in the context of IVT
treatment
Treatment
group
β (95% CI)
for FIV/CBF
Adjusted OR (95% CI)
for 90-d mRS score ≤2
IVT group −1.43 (−1.96 to −0.83) 7.68 (4.33–11.51)
SC group 0.47 (−0.06 to 1.01) 1.71 (0.46–6.37)
Abbreviations: CBF = cerebral blood flow; CI = confidence interval; FIV = final
infarction volume; IVT = intravenous thrombolysis; mRS = modified Rankin
Scale; OR = odds ratio; SC = supportive care; waveletCTA = CT perfusion–
based wavelet-transformed angiography.
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